These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21069925)

  • 1. Confusion on the complexity of calcium balance.
    Moe SM
    Semin Dial; 2010; 23(5):492-7. PubMed ID: 21069925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
    Gotch F; Levin NW; Kotanko P
    Blood Purif; 2010; 29(2):163-76. PubMed ID: 20093823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of dialysate calcium concentration in hemodialysis.
    Toussaint N; Cooney P; Kerr PG
    Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The negative Ca(2+) balance is involved in the stimulation of PTH secretion.
    Yokoyama K; Kagami S; Ohkido I; Kato N; Yamamoto H; Shigematsu T; Nakayama M; Fukagawa M; Kawaguchi Y; Hosoya T
    Nephron; 2002 Sep; 92(1):86-90. PubMed ID: 12187089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.
    Locatelli F; Cannata-Andía JB; Drüeke TB; Hörl WH; Fouque D; Heimburger O; Ritz E
    Nephrol Dial Transplant; 2002 May; 17(5):723-31. PubMed ID: 11981055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium balance during hemodialysis.
    McIntyre CW
    Semin Dial; 2008; 21(1):38-42. PubMed ID: 18251956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration.
    Al-Hejaili F; Kortas C; Leitch R; Heidenheim AP; Clement L; Nesrallah G; Lindsay RM
    J Am Soc Nephrol; 2003 Sep; 14(9):2322-8. PubMed ID: 12937309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of two calcium concentrations in hemodialysis--report of a 20-year clinical experience.
    Seyffart G; Schulz T; Stiller S
    Clin Nephrol; 2009 Mar; 71(3):296-305. PubMed ID: 19281740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium balance in haemodialysis--do not lower the dialysate calcium concentration too much (con part).
    Drüeke TB; Touam M
    Nephrol Dial Transplant; 2009 Oct; 24(10):2990-3. PubMed ID: 19666667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should dialysate calcium concentration be standardised or individualised?
    Lindley EJ
    J Ren Care; 2009 Mar; 35 Suppl 1():101-6. PubMed ID: 19222740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different routes bridging calcium in Japanese hemodialysis patients.
    Hamano T; Fujii N; Ito T; Imai E
    Ther Apher Dial; 2005 Feb; 9(1):32-8. PubMed ID: 15828903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.
    Cancela AL; Oliveira RB; Graciolli FG; dos Reis LM; Barreto F; Barreto DV; Cuppari L; Jorgetti V; Carvalho AB; Canziani ME; Moysés RM
    Nephron Clin Pract; 2011; 117(1):c74-82. PubMed ID: 20689328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum calcium and total calcium load in kidney disease.
    Gupta A; Wang J; Norris K
    Nephrol News Issues; 2003 Nov; 17(12):68-70, 72-4, 76 passim. PubMed ID: 14640013
    [No Abstract]   [Full Text] [Related]  

  • 17. Compounds in development to combat hyperphosphataemia.
    Ritz E; Hergesell O
    Expert Opin Investig Drugs; 2001 Dec; 10(12):2185-90. PubMed ID: 11772314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium metabolism and kidney disease.
    Binswanger U
    Ergeb Inn Med Kinderheilkd; 1974; 34(0):105-53. PubMed ID: 4608434
    [No Abstract]   [Full Text] [Related]  

  • 19. Are calcium-based phosphate binders ever preferable in dialysis patients?
    Jain N; Reilly RF
    Semin Dial; 2014; 27(3):269-72. PubMed ID: 24620781
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium kinetics and the long-term effects of lowering dialysate calcium concentration.
    Argilés A; Kerr PG; Canaud B; Flavier JL; Mion C
    Kidney Int; 1993 Mar; 43(3):630-40. PubMed ID: 8455362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.